1117923

Solaris Pharma Corp — FEI 3012158090

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 9, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Somerset, NJ (United States)

Additional Details

Bioanalytical BA/BE